Pro­teosta­sis shakes up med­ical team; No­vo funds an­tibi­otics ef­forts out of Curza, Spero

→ Po-Shun Lee is hit­ting the ex­it at Pro­teosta­sis Ther­a­peu­tics, trig­ger­ing a pro­mo­tion for Ge­of­frey Gilmartin to fill the CMO seat. Gilmartin, whose pre­vi­ous ti­tle is chief med­ical af­fairs of­fi­cer, will now lead a pre­car­i­ous clin­i­cal jour­ney for the mi­cro­cap biotech’s cys­tic fi­bro­sis dou­blet and triplet drug com­bos as it takes on the mar­ket-lead­ing Ver­tex. Mean­while, An­drey Be­lous has been re­cruit­ed from Gala­pa­gos to be­come a se­nior med­ical di­rec­tor. 

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER